Navigation Links
SpineSmith Partners Announces FDA Clearance and Product Launch of VisuALIF Interbody Fusion Device at North American Spine Society Annual Meeting

AUSTIN, Texas, Oct. 7 /PRNewswire/ -- SpineSmith Partners, a Texas-based medical device company, today announced the company has received FDA clearance for commercial sale in the United States of its VisuALIF Interbody Fusion Implant System.  The VisuALIF System is being launched this week and is currently on display at the North American Spine Society's annual meeting in Orlando, Florida.

The VisuALIF is a two-piece, stand alone device indicated for intervertebral body fusion of the lumbar spine.  VisuALIF is the first modular lumbar interbody device with an open-face allowing in situ graft placement, tactile feedback with face plate attachment and device placement flush with the anterior aspect of the vertebrae.  The device is available in a range of product sizes and configurations designed to meet surgeon requirements across a wide spectrum of patient anatomy.  

SpineSmith's General Partner, Kevin Dunworth, believes the VisuALIF will offer a unique solution for surgeons.  

"The VisuALIF incorporates an anterior open-face allowing surgeons to visualize disc and end plate preparation leading to optimum graft placement with respect to available volume.  With our launch at NASS, the VisuALIF is 'Now Open for Fusion,'" said Dunworth.

About SpineSmith Partners LP

SpineSmith Partners, LP designs, develops and markets implants and biologics for surgical fixation, correction and tissue regeneration of the spine. SpineSmith takes a different approach from other companies, utilizing a collaborative approach between scientists, engineers and spine surgeons. It's this unique approach that gives spine surgeons the ability to directly impact the direction of their product portfolio, ensuring applicability and achieving the highest standards of patient care.

Founded in Austin, Texas, in 2006, SpineSmith has developed a range of devices with direct surgeon input into the design of spine technology.

SOURCE SpineSmith Partners, LP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
2. SpineSmith Partners and Celling Technologies Hire New VP of Research and Development
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
7. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
8. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
9. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
10. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
11. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
Post Your Comments:
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):